期刊文献+

结直肠癌的分子生物学诊断进展 被引量:7

下载PDF
导出
摘要 结直肠癌(colorectal cancer,CRC)是我国发病率最高的三大肿瘤之一,并且每年以4.2%的速度增长,远超2%的国际增长水平。CRC的死亡率居国内恶性肿瘤死亡的前五位,其术后生存率与诊断时的临床分期明显相关:肿瘤局限在结直肠的早期患者(DukesA期)在肿瘤完全切除术后的5年生存率能达到90%,
作者 程卫 邱辉忠
出处 《癌症进展》 2013年第1期22-25,30,共5页 Oncology Progress
  • 相关文献

参考文献4

二级参考文献41

  • 1张思维,雷正龙,李光琳,邹小农,陈万青,赵平.中国肿瘤登记地区2005年发病死亡资料分析[J].中国肿瘤,2009,18(12):973-979. 被引量:32
  • 2陈竺.全国第三次死因回顾抽样调查报告[M].北京:中国协和医科大学出版社,2008:11-12.
  • 3Herman JG,Baylin SB.Gene silencing in cancer in association with promoter Hypermethy-lation[J].N Engl J Med,2003,349(21):2042-2054.
  • 4Lee BB,Lee EJ,Jung EH,et al.Aberrant methylation of APC,MGMT,RASSF2A,and Wif-1 genes in plasma as a biomarker for early detection of colorectal cancer[J].Clin Cancer Res,2009,15(19):6185-6191.
  • 5Ahlquist T,Lind GE,Costa VL,et al.Gene methylation profiles of normal mucosa,and benign and malignant colorectal tumors identify early onset markers[J].Mol Cancer,2008,7:94.
  • 6Krakowczyk L,Strzelczyk JK,Adamek B,et al.Methylation of the MGMT and p16 genes in sporadic colorectal carcinoma and corresponding normal colonic mucosa[J].Med Sci Monit,2008,14(10):219-225.
  • 7Chan AO,Rashid A.CpG island methylation in precursors of gastrointestinal malignancies[J].Curr Mol Med,2006,6(4):401-408.
  • 8Toyota M,Ahuja N,Ohe-Toyota M,et al.CpG island methylator phenotype in colorectal cancer[J].Proc Natl Acad Sci USA,1999,96(15):8681-8686.
  • 9Samowitz WS,Albertsen H,Herrick J,et al.Evaluation of a large,population-based sample supports a CpG island methylator phenotype in colon cancer[J].Gastroenterology,2005,129(3):837-845.
  • 10Barault L,Charon-Barra C,Jooste V,et al.Hypermethylator phenotype in sporadic colon cancer:study on a population-based series of 582 cases[J].Cancer Res,2008,68(20):8541-8546.

共引文献584

同被引文献55

  • 1刘珣,王海连.CEA、CA19-9、CA50、CA125监测在胆囊癌早期诊断和预后判断中的应用[J].中国误诊学杂志,2009,9(3):577-578. 被引量:14
  • 2吕晓娴,刘冰,张瑞丽.血清CEA和CA199及CA724联合检测对胃癌诊断的临床意义[J].中国肿瘤临床与康复,2007,14(1):26-28. 被引量:30
  • 3郇天笑,王泽,张辉,白增亮.甲胎蛋白分子演化的生物信息学分析[J].山东大学学报(理学版),2007,42(3):78-83. 被引量:2
  • 4Ishizuka M, Nagata H, Takagi K, et al. Clinical significance of tumor pathology for postoperative survival of patients undergoing surgery for stage IV colorectal cancer [ J ]. Anticancer Res, 2012, 32:3291-3297.
  • 5Kim YB, Jeung HC, Jeong I, et al. Mechanism of enhancement of radiation-induced cytotoxicity by sorafenib in colorectal cancer [J]. J Radiat Res, 2013, 54:52-60.
  • 6Greuter MJ,Xu XM,Lew JB,et al. Modeling the Adenoma and Serrated Pathway to Colarectal CAncer (ASCCA) [ J]. Risk A- nal, 2014, 34:889-910.
  • 7Mndez Romero A, Verheij J, Dwarkasing RS, et al. Comparison of macroscopic pathology measurements with magnetic reso- nance imaging and assessment of microscopic pathology exten- sion for colorectal liver metastases[J]. Int J Radiat Oncol Biol Phys, 2012, 82:159-166.
  • 8Adachi Y,T suchihas hi J,Sh irais hi N,et al.AFP producing gastric carcinoma:Multivariate analysis of prognostic factors in 270patients[J].Oncology,2003,65(2):95.
  • 9Holmgreen EJ.Detection by monocloral ant ibady of carbohgdrate antigen CA50 in serum of patient with carcinoma[J].Br Med J,1984,288:1479.
  • 10Kuusela P,Haglund C,Roberts PJ.Comparison of a new tumour marker CA242 with CA19-9,CA50 and carcinoembryonic antigen(CEA)in digestive tract diseases[J].Br J Cancer,1991,63(4):636.

引证文献7

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部